131 related articles for article (PubMed ID: 21846141)
1. Composition and mechanism of antitumor effects of Hericium erinaceus mushroom extracts in tumor-bearing mice.
Kim SP; Kang MY; Kim JH; Nam SH; Friedman M
J Agric Food Chem; 2011 Sep; 59(18):9861-9. PubMed ID: 21846141
[TBL] [Abstract][Full Text] [Related]
2. Antitumor effects of dietary black and brown rice brans in tumor-bearing mice: relationship to composition.
Choi SP; Kim SP; Nam SH; Friedman M
Mol Nutr Food Res; 2013 Mar; 57(3):390-400. PubMed ID: 23281142
[TBL] [Abstract][Full Text] [Related]
3. Hericium erinaceus (Lion's Mane) mushroom extracts inhibit metastasis of cancer cells to the lung in CT-26 colon cancer-tansplanted mice.
Kim SP; Nam SH; Friedman M
J Agric Food Chem; 2013 May; 61(20):4898-904. PubMed ID: 23668749
[TBL] [Abstract][Full Text] [Related]
4. Hericium erinaceus mushroom extracts protect infected mice against Salmonella Typhimurium-Induced liver damage and mortality by stimulation of innate immune cells.
Kim SP; Moon E; Nam SH; Friedman M
J Agric Food Chem; 2012 Jun; 60(22):5590-6. PubMed ID: 22624604
[TBL] [Abstract][Full Text] [Related]
5. Dietary rice bran component γ-oryzanol inhibits tumor growth in tumor-bearing mice.
Kim SP; Kang MY; Nam SH; Friedman M
Mol Nutr Food Res; 2012 Jun; 56(6):935-44. PubMed ID: 22707268
[TBL] [Abstract][Full Text] [Related]
6. Antitumor and antimetastatic activity of a novel water-soluble low molecular weight beta-1, 3-D-glucan (branch beta-1,6) isolated from Aureobasidium pullulans 1A1 strain black yeast.
Kimura Y; Sumiyoshi M; Suzuki T; Sakanaka M
Anticancer Res; 2006; 26(6B):4131-41. PubMed ID: 17201124
[TBL] [Abstract][Full Text] [Related]
7. Production of interleukin 15 by human colon cancer cells is associated with induction of mucosal hyperplasia, angiogenesis, and metastasis.
Kuniyasu H; Ohmori H; Sasaki T; Sasahira T; Yoshida K; Kitadai Y; Fidler IJ
Clin Cancer Res; 2003 Oct; 9(13):4802-10. PubMed ID: 14581351
[TBL] [Abstract][Full Text] [Related]
8. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer.
Wang L; Chen W; Xie X; He Y; Bai X
Exp Oncol; 2008 Mar; 30(1):42-51. PubMed ID: 18438340
[TBL] [Abstract][Full Text] [Related]
9. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
[TBL] [Abstract][Full Text] [Related]
10. Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells.
Ciardiello F; Bianco R; Damiano V; Fontanini G; Caputo R; Pomatico G; De Placido S; Bianco AR; Mendelsohn J; Tortora G
Clin Cancer Res; 2000 Sep; 6(9):3739-47. PubMed ID: 10999768
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effect of interleukin 7 in combination with local hyperthermia in mice bearing B16a melanoma cells.
Wu B; Shen RN; Wang WX; Broxmeyer HE; Lu L
Stem Cells; 1993 Sep; 11(5):412-21. PubMed ID: 8241952
[TBL] [Abstract][Full Text] [Related]
12. Circulating angiogenic growth factor levels in mice bearing human tumors using Luminex Multiplex technology.
Keyes KA; Mann L; Cox K; Treadway P; Iversen P; Chen YF; Teicher BA
Cancer Chemother Pharmacol; 2003 Apr; 51(4):321-7. PubMed ID: 12721760
[TBL] [Abstract][Full Text] [Related]
13. Ethanol suppression of the hypothalamic proopiomelanocortin level and the splenic NK cell cytolytic activity is associated with a reduction in the expression of proinflammatory cytokines but not anti-inflammatory cytokines in neuroendocrine and immune cells.
Chen CP; Boyadjieva NI; Advis JP; Sarkar DK
Alcohol Clin Exp Res; 2006 Nov; 30(11):1925-32. PubMed ID: 17067358
[TBL] [Abstract][Full Text] [Related]
14. Interferon-inducible protein 10 induction and inhibition of angiogenesis in vivo by the antitumor agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA).
Cao Z; Baguley BC; Ching LM
Cancer Res; 2001 Feb; 61(4):1517-21. PubMed ID: 11245459
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis.
Huang S; Xie K; Bucana CD; Ullrich SE; Bar-Eli M
Clin Cancer Res; 1996 Dec; 2(12):1969-79. PubMed ID: 9816156
[TBL] [Abstract][Full Text] [Related]
16. Anti-tumor effects of polybutylcyanoacrylate nanoparticles of diallyl trisulfide on orthotopic transplantation tumor model of hepatocellular carcinoma in BALB/c nude mice.
Zhang ZM; Yang XY; Deng SH; Xu W; Gao HQ
Chin Med J (Engl); 2007 Aug; 120(15):1336-42. PubMed ID: 17711740
[TBL] [Abstract][Full Text] [Related]
17. Effect of cyclooxygenase and nitric oxide synthase inhibitors on tumor growth in mouse tumor models with and without cancer cachexia related to prostanoids.
Cahlin C; Gelin J; Delbro D; Lönnroth C; Doi C; Lundholm K
Cancer Res; 2000 Mar; 60(6):1742-9. PubMed ID: 10749148
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 12 primes macrophages for nitric oxide production in vivo and restores depressed nitric oxide production by macrophages from tumor-bearing mice: implications for the antitumor activity of interleukin 12 and/or interleukin 2.
Wigginton JM; Kuhns DB; Back TC; Brunda MJ; Wiltrout RH; Cox GW
Cancer Res; 1996 Mar; 56(5):1131-6. PubMed ID: 8640772
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effects of cyclooxygenase-2 inhibitor celecoxib against toxicity of LPS-stimulated macrophages toward motor neurons.
Huang Y; Liu J; Wang LZ; Zhang WY; Zhu XZ
Acta Pharmacol Sin; 2005 Aug; 26(8):952-8. PubMed ID: 16038627
[TBL] [Abstract][Full Text] [Related]
20. Local release of interleukin-10 by transfected mouse adenocarcinoma cells exhibits pro- and anti-inflammatory activity and results in a delayed tumor rejection.
Di Carlo E; Coletti A; Modesti A; Giovarelli M; Forni G; Musiani P
Eur Cytokine Netw; 1998 Mar; 9(1):61-8. PubMed ID: 9613679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]